approval
saveNURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalAug 1, 2025 · 436d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 21, 2025 · 569d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 12, 2024 · 668d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalApr 11, 2022 · 1644d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 31, 2022 · 1655d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 8, 2021 · 1768d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMay 27, 2021 · 1963d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalAug 18, 2020 · 2245d ago
same company · ±60 days · 6
- approvalelranatamab: ELREXFIO (ELRANATAMAB) — FDA approvalMar 25, 2026
- approvalCLEOCIN: CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalMar 26, 2026
- approvalclindamycin hydrochloride: CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalMar 26, 2026
- approvalCLEOCIN: CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approvalMar 26, 2026
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalMar 6, 2026
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalMar 6, 2026
comments(0)
5-min edit window · permanent after that